MONOCLONAL ANTIBODIES AGAINST THE RGM A PROTEIN AND USES THEREOF

摘要

The invention relates to monoclonal antibodies, which have the ability for detecting RGM A and for inhibiting RGM A activity, for example in a human suffering from a disorder including but not limited to multiple sclerosis, mammalian brain trauma, spinal cord injury, stroke, neurodegenerative diseases, and schizophrenia.